{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T23:37:26Z","timestamp":1780097846932,"version":"3.54.0"},"reference-count":99,"publisher":"Georg Thieme Verlag KG","issue":"01","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Semin Liver Dis"],"published-print":{"date-parts":[[2021,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Alcohol use disorder is the predominant cause of chronic liver disease globally. The standard of care for the treatment of alcoholic hepatitis, corticosteroids, has been shown to provide a therapeutic response in \u223c60% of carefully selected patients with a short-term survival benefit. The patients who do not respond to steroids, or are ineligible due to infections or very severe disease, have little options other than liver transplantation. There is, thus, a large unmet need for new therapeutic strategies for this large and sick group of patients. Granulocyte colony stimulating factor (G-CSF) has been shown to favorably modulate the intrahepatic immune milieu and stimulate the regenerative potential of the liver. Initial studies have shown encouraging results with G-CSF in patients with severe alcoholic hepatitis. It has also been found to help steroid nonresponsive patients. There is, however, a need for careful selection of patients, regular dose monitoring and close observation for adverse events of G-CSF. In this review, we analyze the basis of the potential benefits, clinical studies, cautions and challenges in the use of G-CSF in alcoholic hepatitis.<\/jats:p>","DOI":"10.1055\/s-0040-1719177","type":"journal-article","created":{"date-parts":[[2021,2,10]],"date-time":"2021-02-10T00:53:23Z","timestamp":1612918403000},"page":"067-078","source":"Crossref","is-referenced-by-count":11,"title":["Insights into the Role of Granulocyte Colony-Stimulating Factor in Severe Alcoholic Hepatitis"],"prefix":"10.1055","volume":"41","author":[{"given":"Chandan Kumar","family":"Kedarisetty","sequence":"additional","affiliation":[{"name":"Department of Hepatology, Institute of Liver and Biliary Sciences, New Delhi, India"},{"name":"Department of Hepatology, Sri Ramachandra Institute of Higher Education and Research, Chennai, Tamil Nadu, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anupam","family":"Kumar","sequence":"additional","affiliation":[{"name":"Department of Molecular and Cellular Medicine, Institute of Liver and Biliary Sciences, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiv Kumar","family":"Sarin","sequence":"additional","affiliation":[{"name":"Department of Hepatology, Institute of Liver and Biliary Sciences, New Delhi, India"},{"name":"Department of Molecular and Cellular Medicine, Institute of Liver and Biliary Sciences, New Delhi, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"194","published-online":{"date-parts":[[2021,2,9]]},"reference":[{"issue":"01","key":"ref1","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jhep.2018.09.014","article-title":"Burden of liver diseases in the world","volume":"70","author":"S K Asrani","year":"2019","journal-title":"J Hepatol"},{"issue":"04","key":"ref2","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.cld.2012.08.005","article-title":"Diagnosis and management of alcoholic hepatitis","volume":"16","author":"U Sohail","year":"2012","journal-title":"Clin Liver Dis"},{"issue":"04","key":"ref3","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1053\/j.gastro.2016.02.042","article-title":"Standard definitions and common data elements for clinical trials in patients with alcoholic hepatitis: recommendation from the NIAAA alcoholic hepatitis consortia","volume":"150","author":"D W Crabb","year":"2016","journal-title":"Gastroenterology"},{"issue":"05","key":"ref4","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1053\/j.gastro.2014.01.018","article-title":"A histologic scoring system for prognosis of patients with alcoholic hepatitis","volume":"146","author":"J Altamirano","year":"2014","journal-title":"Gastroenterology"},{"issue":"03","key":"ref5","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s12072-017-9790-5","article-title":"New paradigms in management of alcoholic hepatitis: a review","volume":"11","author":"S S Sidhu","year":"2017","journal-title":"Hepatol Int"},{"issue":"01","key":"ref6","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1002\/hep.23258","article-title":"Alcoholic liver disease","volume":"51","author":"R S O'Shea","year":"2010","journal-title":"Hepatology"},{"issue":"04","key":"ref7","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.jceh.2013.11.005","article-title":"Combination therapy in severe alcoholic hepatitis-doesn't really work","volume":"3","author":"A Duseja","year":"2013","journal-title":"J Clin Exp Hepatol"},{"issue":"04","key":"ref8","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1189\/jlb.6A0114-004RR","article-title":"Chronic alcohol ingestion modulates hepatic macrophage populations and functions in mice","volume":"96","author":"M Wang","year":"2014","journal-title":"J Leukoc Biol"},{"issue":"01","key":"ref9","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/hep.27383","article-title":"Osteopontin deficiency does not prevent but promotes alcoholic neutrophilic hepatitis in mice","volume":"61","author":"R Lazaro","year":"2015","journal-title":"Hepatology"},{"issue":"S 02","key":"ref10","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1007\/s12072-014-9538-4","article-title":"Growth factors enhance liver regeneration in acute-on-chronic liver failure","volume":"8","author":"C K Kedarisetty","year":"2014","journal-title":"Hepatol Int"},{"issue":"04","key":"ref11","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/nrgastro.2015.35","article-title":"Alcoholic liver disease: mechanisms of injury and targeted treatment","volume":"12","author":"A Louvet","year":"2015","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"04","key":"ref12","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1136\/gutjnl-2016-311861","article-title":"MicroRNA-223 ameliorates alcoholic liver injury by inhibiting the IL-6-p47phox-oxidative stress pathway in neutrophils","volume":"66","author":"M Li","year":"2017","journal-title":"Gut"},{"issue":"05","key":"ref13","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1002\/hep.26169","article-title":"Macrophage migration inhibitory factor contributes to ethanol-induced liver injury by mediating cell injury, steatohepatitis, and steatosis","volume":"57","author":"M A Barnes","year":"2013","journal-title":"Hepatology"},{"issue":"05","key":"ref14","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1016\/j.jhep.2017.06.014","article-title":"Hepatocyte-derived macrophage migration inhibitory factor mediates alcohol-induced liver injury in mice and patients","volume":"67","author":"V Marin","year":"2017","journal-title":"J Hepatol"},{"issue":"04","key":"ref15","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/j.jhep.2014.05.024","article-title":"Inhibition of heat shock protein 90 alleviates steatosis and macrophage activation in murine alcoholic liver injury","volume":"61","author":"A Ambade","year":"2014","journal-title":"J Hepatol"},{"issue":"03","key":"ref16","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.jhep.2015.04.003","article-title":"Hepatic cell proliferation plays a pivotal role in the prognosis of alcoholic hepatitis","volume":"63","author":"N Lanthier","year":"2015","journal-title":"J Hepatol"},{"issue":"03","key":"ref17","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1007\/s00441-017-2753-2","article-title":"Partners in crime: neutrophils and monocytes\/macrophages in inflammation and disease","volume":"371","author":"K Prame Kumar","year":"2018","journal-title":"Cell Tissue Res"},{"issue":"14","key":"ref18","doi-asserted-by":"crossref","first-page":"92634","DOI":"10.1172\/jci.insight.92634","article-title":"Mitochondrial DNA-enriched microparticles promote acute-on-chronic alcoholic neutrophilia and hepatotoxicity","volume":"2","author":"Y Cai","year":"2017","journal-title":"JCI Insight"},{"issue":"05","key":"ref19","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1053\/j.gastro.2009.01.056","article-title":"Hepatic expression of CXC chemokines predicts portal hypertension and survival in patients with alcoholic hepatitis","volume":"136","author":"M Dominguez","year":"2009","journal-title":"Gastroenterology"},{"issue":"02","key":"ref20","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1002\/hep.1840060217","article-title":"Abnormalities of neutrophil phagocytosis, intracellular killing and metabolic activity in alcoholic cirrhosis and hepatitis","volume":"6","author":"I A Rajkovic","year":"1986","journal-title":"Hepatology"},{"issue":"03","key":"ref21","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1002\/hep.21737","article-title":"Neutrophil dysfunction in alcoholic hepatitis superimposed on cirrhosis is reversible and predicts the outcome","volume":"46","author":"R P Mookerjee","year":"2007","journal-title":"Hepatology"},{"issue":"S 01","key":"ref22","doi-asserted-by":"crossref","first-page":"E59","DOI":"10.1111\/j.1530-0277.2012.01852.x","article-title":"Chronic ethanol feeding alters miRNA expression dynamics during liver regeneration","volume":"37","author":"R P Dippold","year":"2013","journal-title":"Alcohol Clin Exp Res"},{"issue":"05","key":"ref23","doi-asserted-by":"crossref","first-page":"G794","DOI":"10.1152\/ajpgi.00292.2016","article-title":"Inhibition of miR-21 rescues liver regeneration after partial hepatectomy in ethanol-fed rats","volume":"311","author":"E Juskeviciute","year":"2016","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/S0140-6736(94)92025-7","article-title":"Hepatocyte proliferation as an indicator of outcome in acute alcoholic hepatitis","volume":"343","author":"J W Fang","year":"1994","journal-title":"Lancet"},{"issue":"03","key":"ref25","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.yexmp.2016.05.009","article-title":"What are the mechanisms of regeneration inhibition in alcoholic hepatitis?","volume":"100","author":"S W French","year":"2016","journal-title":"Exp Mol Pathol"},{"issue":"12","key":"ref26","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1136\/gutjnl-2014-308410","article-title":"Progenitor cell expansion and impaired hepatocyte regeneration in explanted livers from alcoholic hepatitis","volume":"64","author":"L Dubuquoy","year":"2015","journal-title":"Gut"},{"issue":"06","key":"ref27","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1002\/hep.25614","article-title":"Liver progenitor cell markers correlate with liver damage and predict short-term mortality in patients with alcoholic hepatitis","volume":"55","author":"P Sancho-Bru","year":"2012","journal-title":"Hepatology"},{"issue":"06","key":"ref28","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1007\/s12072-019-09983-y","article-title":"Cellular and functional loss of liver endothelial cells correlates with poor hepatocyte regeneration in acute-on-chronic liver failure","volume":"13","author":"S Shubham","year":"2019","journal-title":"Hepatol Int"},{"issue":"04","key":"ref29","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1172\/JCI132691","article-title":"Epithelial splicing regulatory protein 2-mediated alternative splicing reprograms hepatocytes in severe alcoholic hepatitis","volume":"130","author":"J Hyun","year":"2020","journal-title":"J Clin Invest"},{"issue":"05","key":"ref30","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1002\/hep.30472","article-title":"Ductular reaction cells display an inflammatory profile and recruit neutrophils in alcoholic hepatitis","volume":"69","author":"B Aguilar-Bravo","year":"2019","journal-title":"Hepatology"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"35610","DOI":"10.1038\/srep35610","article-title":"LPS-TLR4 pathway mediates ductular cell expansion in alcoholic hepatitis","volume":"6","author":"G Odena","year":"2016","journal-title":"Sci Rep"},{"issue":"02","key":"ref32","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0016-5085(78)90401-8","article-title":"Corticosteroid therapy of alcoholic hepatitis","volume":"75","author":"W C Maddrey","year":"1978","journal-title":"Gastroenterology"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1002\/hep.30866","article-title":"Diagnosis and treatment of alcohol related liver diseases: 2019 Practice Guidance from American Association for the Study of Liver Diseases","author":"D W Crabb","year":"2019","journal-title":"Hepatology"},{"issue":"02","key":"ref34","doi-asserted-by":"crossref","first-page":"e0192393","DOI":"10.1371\/journal.pone.0192393","article-title":"Survival from alcoholic hepatitis has not improved over time","volume":"13","author":"E Hughes","year":"2018","journal-title":"PLoS One"},{"issue":"06","key":"ref35","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1111\/apt.12427","article-title":"Determinants of long-term outcome in severe alcoholic hepatitis","volume":"38","author":"J R Potts","year":"2013","journal-title":"Aliment Pharmacol Ther"},{"issue":"01","key":"ref36","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1002\/hep.30358","article-title":"Diagnosis and treatment of alcohol use disorder in patients with end-stage alcoholic liver disease","volume":"70","author":"F Caputo","year":"2019","journal-title":"Hepatology"},{"issue":"02","key":"ref37","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1093\/alcalc\/agu096","article-title":"Assessing and treating alcohol relapse risk in liver transplantation candidates","volume":"50","author":"G Dom","year":"2015","journal-title":"Alcohol Alcohol"},{"issue":"07","key":"ref38","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1111\/eci.12767","article-title":"Treatment of severe alcoholic hepatitis: past, present and future","volume":"47","author":"N Lanthier","year":"2017","journal-title":"Eur J Clin Invest"},{"issue":"06","key":"ref39","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1002\/hep.21607","article-title":"The Lille model: a new tool for therapeutic strategy in patients with severe alcoholic hepatitis treated with steroids","volume":"45","author":"A Louvet","year":"2007","journal-title":"Hepatology"},{"issue":"17","key":"ref40","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1056\/NEJMoa1412278","article-title":"Prednisolone or pentoxifylline for alcoholic hepatitis","volume":"372","author":"M R Thursz","year":"2015","journal-title":"N Engl J Med"},{"issue":"19","key":"ref41","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1056\/NEJMoa1101214","article-title":"Glucocorticoids plus N-acetylcysteine in severe alcoholic hepatitis","volume":"365","author":"E Nguyen-Khac","year":"2011","journal-title":"N Engl J Med"},{"issue":"04","key":"ref42","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.cgh.2013.06.013","article-title":"Alcoholic hepatitis: current challenges and future directions","volume":"12","author":"A K Singal","year":"2014","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"06","key":"ref43","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1016\/j.hep.2003.09.038","article-title":"Early change in bilirubin levels is an important prognostic factor in severe alcoholic hepatitis treated with prednisolone","volume":"38","author":"P Mathurin","year":"2003","journal-title":"Hepatology"},{"issue":"02","key":"ref44","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1136\/gut.2010.224097","article-title":"Corticosteroids improve short-term survival in patients with severe alcoholic hepatitis: meta-analysis of individual patient data","volume":"60","author":"P Mathurin","year":"2011","journal-title":"Gut"},{"key":"ref45","first-page":"963A","article-title":"Bilirubin evolution before corticosteroid has a major prognostic value in severe alcoholic hepatitis","volume":"56","author":"M A Freyssinet","year":"2012","journal-title":"Hepatology"},{"issue":"02","key":"ref46","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1053\/j.gastro.2009.04.062","article-title":"Infection in patients with severe alcoholic hepatitis treated with steroids: early response to therapy is the key factor","volume":"137","author":"A Louvet","year":"2009","journal-title":"Gastroenterology"},{"issue":"06","key":"ref47","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1002\/hep4.1176","article-title":"Baseline urine metabolic phenotype in patients with severe alcoholic hepatitis and its association with outcome","volume":"2","author":"J S Maras","year":"2018","journal-title":"Hepatol Commun"},{"issue":"08","key":"ref48","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1111\/apt.14564","article-title":"Microvesicles in hepatic and peripheral vein can predict nonresponse to corticosteroid therapy in severe alcoholic hepatitis","volume":"47","author":"S Sukriti","year":"2018","journal-title":"Aliment Pharmacol Ther"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1242\/jcs.1990.Supplement_13.7","article-title":"The biochemistry and biology of the myeloid haemopoietic cell growth factors","volume":"13","author":"C M Heyworth","year":"1990","journal-title":"J Cell Sci Suppl"},{"issue":"03","key":"ref50","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.4049\/jimmunol.122.3.1134","article-title":"Stimulation by granulocyte-macrophage colony-stimulating factor of Leishmania tropica killing by macrophages","volume":"122","author":"E Handman","year":"1979","journal-title":"J Immunol"},{"issue":"03","key":"ref51","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1002\/jcp.1041030309","article-title":"Stimulation of macrophage plasminogen activator activity by colony-stimulating factors","volume":"103","author":"J A Hamilton","year":"1980","journal-title":"J Cell Physiol"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/339027a0","article-title":"The molecular control of cell division, differentiation commitment and maturation in haemopoietic cells","volume":"339","author":"D Metcalf","year":"1989","journal-title":"Nature"},{"issue":"04","key":"ref53","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1084\/jem.165.4.941","article-title":"Recombinant human granulocyte colony-stimulating factor. Effects on hematopoiesis in normal and cyclophosphamide-treated primates","volume":"165","author":"K Welte","year":"1987","journal-title":"J Exp Med"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1146\/annurev.bi.65.070196.003141","article-title":"Hematopoietic receptor complexes","volume":"65","author":"J A Wells","year":"1996","journal-title":"Annu Rev Biochem"},{"issue":"06","key":"ref55","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1182\/blood.V88.6.1907.bloodjournal8861907","article-title":"Filgrastim (r-metHuG-CSF): the first 10 years","volume":"88","author":"K Welte","year":"1996","journal-title":"Blood"},{"key":"ref56","volume-title":"Hematology: Basic Principles and Practice","author":"R Hoffman","year":"2018","edition":"7th edition."},{"issue":"11","key":"ref57","doi-asserted-by":"crossref","first-page":"2791","DOI":"10.1182\/blood.V78.11.2791.bloodjournal78112791","article-title":"Granulocyte colony-stimulating factor and its receptor","volume":"78","author":"G D Demetri","year":"1991","journal-title":"Blood"},{"issue":"04","key":"ref58","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1002\/bies.950050407","article-title":"Molecular biology of T-cell-derived lymphokines: a model system for proliferation and differentiation of hemopoietic cells","volume":"5","author":"K Arai","year":"1986","journal-title":"BioEssays"},{"issue":"02","key":"ref59","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s00520-002-0394-8","article-title":"Granulocyte transfusions from G-CSF-stimulated donors for the treatment of severe infections in neutropenic pediatric patients with onco-hematological diseases","volume":"11","author":"S Cesaro","year":"2003","journal-title":"Support Care Cancer"},{"issue":"04","key":"ref60","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1002\/bies.950100405","article-title":"Gene structure and function of granulocyte colony-stimulating factor","volume":"10","author":"S Nagata","year":"1989","journal-title":"BioEssays"},{"issue":"01","key":"ref61","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1182\/blood.V68.1.162.162","article-title":"Purified colony-stimulating factors enhance the survival of human neutrophils and eosinophils in vitro: a rapid and sensitive microassay for colony-stimulating factors","volume":"68","author":"C G Begley","year":"1986","journal-title":"Blood"},{"issue":"04","key":"ref62","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.cytogfr.2014.07.011","article-title":"G-CSF: From granulopoietic stimulant to bone marrow stem cell mobilizing agent","volume":"25","author":"L J Bendall","year":"2014","journal-title":"Cytokine Growth Factor Rev"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.pharmthera.2019.03.001","article-title":"Alcohol abuse and disorder of granulopoiesis","volume":"198","author":"X Shi","year":"2019","journal-title":"Pharmacol Ther"},{"issue":"03","key":"ref64","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.4049\/jimmunol.182.3.1568","article-title":"Acute alcohol intoxication inhibits the lineage- c-kit+ Sca-1+ cell response to Escherichia coli bacteremia","volume":"182","author":"P Zhang","year":"2009","journal-title":"J Immunol"},{"key":"ref65","doi-asserted-by":"crossref","first-page":"d1314","DOI":"10.2741\/A842","article-title":"Pulmonary host defenses and alcohol","volume":"7","author":"P Zhang","year":"2002","journal-title":"Front Biosci"},{"issue":"02","key":"ref66","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1111\/j.1530-0277.2008.00842.x","article-title":"A recent perspective on alcohol, immunity, and host defense","volume":"33","author":"G Szabo","year":"2009","journal-title":"Alcohol Clin Exp Res"},{"issue":"01","key":"ref67","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1378\/chest.107.1.214","article-title":"Rapidly fatal outcome of bacteremic Klebsiella pneumoniae pneumonia in alcoholics","volume":"107","author":"G M Jong","year":"1995","journal-title":"Chest"},{"issue":"04","key":"ref68","first-page":"757","article-title":"Alcoholism, leukopenia, and pneumococcal sepsis","volume":"132","author":"C A Perlino","year":"1985","journal-title":"Am Rev Respir Dis"},{"issue":"02","key":"ref69","first-page":"152","article-title":"Infections in severe alcoholic hepatitis","volume":"30","author":"E Karakike","year":"2017","journal-title":"Ann Gastroenterol"},{"issue":"10","key":"ref70","doi-asserted-by":"crossref","first-page":"2542","DOI":"10.3748\/wjg.v20.i10.2542","article-title":"Risk factors and outcome of bacterial infections in cirrhosis","volume":"20","author":"T Bruns","year":"2014","journal-title":"World J Gastroenterol"},{"issue":"10","key":"ref71","first-page":"CD003039","article-title":"Colony-stimulating factors for chemotherapy-induced febrile neutropenia","author":"R Mhaskar","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"issue":"02","key":"ref72","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.jhep.2004.10.019","article-title":"Patients with acute on chronic liver failure display \u201csepsis-like\u201d immune paralysis","volume":"42","author":"H E Wasmuth","year":"2005","journal-title":"J Hepatol"},{"issue":"12","key":"ref73","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1084\/jem.20021598","article-title":"Efficient targeting of protein antigen to the dendritic cell receptor DEC-205 in the steady state leads to antigen presentation on major histocompatibility complex class I products and peripheral CD8+ T cell tolerance","volume":"196","author":"L Bonifaz","year":"2002","journal-title":"J Exp Med"},{"issue":"06","key":"ref74","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.3390\/ijms18061115","article-title":"The cytokine Flt3-ligand in normal and malignant hematopoiesis","volume":"18","author":"P Tsapogas","year":"2017","journal-title":"Int J Mol Sci"},{"issue":"06","key":"ref75","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1002\/hep.21974","article-title":"Dendritic cells, the liver, and transplantation","volume":"46","author":"T L Sumpter","year":"2007","journal-title":"Hepatology"},{"issue":"04","key":"ref76","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1002\/hep.21098","article-title":"Functional modification of CD11c+ liver dendritic cells during liver regeneration after partial hepatectomy in mice","volume":"43","author":"A Castellaneta","year":"2006","journal-title":"Hepatology"},{"issue":"04","key":"ref77","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1111\/liv.12415","article-title":"Altered frequencies of dendritic cells and IFN-\u03b3-secreting T cells with granulocyte colony-stimulating factor (G-CSF) therapy in acute-on- chronic liver failure","volume":"34","author":"A Khanam","year":"2014","journal-title":"Liver Int"},{"issue":"02","key":"ref78","doi-asserted-by":"crossref","first-page":"45S","DOI":"10.1097\/PRS.0b013e318191be4a","article-title":"Mesenchymal stem cells can participate in ischemic neovascularization","volume":"123","author":"C Hamou","year":"2009","journal-title":"Plast Reconstr Surg"},{"issue":"08","key":"ref79","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1634\/stemcells.2007-0922","article-title":"Evidence that very small embryonic-like stem cells are mobilized into peripheral blood","volume":"26","author":"M J Kucia","year":"2008","journal-title":"Stem Cells"},{"issue":"10","key":"ref80","doi-asserted-by":"crossref","first-page":"3025","DOI":"10.1182\/blood.V95.10.3025","article-title":"Expression of the G-CSF receptor on hematopoietic progenitor cells is not required for their mobilization by G-CSF","volume":"95","author":"F Liu","year":"2000","journal-title":"Blood"},{"issue":"01","key":"ref81","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.exphem.2004.09.005","article-title":"G-CSF-primed hematopoietic stem cells or G-CSF per se accelerate recovery and improve survival after liver injury, predominantly by promoting endogenous repair programs","volume":"33","author":"E Yannaki","year":"2005","journal-title":"Exp Hematol"},{"issue":"04","key":"ref82","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1002\/hep.28754","article-title":"Bone marrow stem cells and their niche components are adversely affected in advanced cirrhosis of the liver","volume":"64","author":"C Bihari","year":"2016","journal-title":"Hepatology"},{"issue":"01","key":"ref83","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/liv.13923","article-title":"Early cirrhosis and a preserved bone marrow niche favour regenerative response to growth factors in decompensated cirrhosis","volume":"39","author":"L Anand","year":"2019","journal-title":"Liver Int"},{"issue":"09","key":"ref84","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1023\/A:1025463532521","article-title":"Granulocyte-colony stimulating factor administration ameliorates liver regeneration in animal model of fulminant hepatic failure and encephalopathy","volume":"48","author":"S E Theocharis","year":"2003","journal-title":"Dig Dis Sci"},{"issue":"02","key":"ref85","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1053\/j.gastro.2007.05.018","article-title":"Granulocyte-colony stimulating factor promotes liver repair and induces oval cell migration and proliferation in rats","volume":"133","author":"A C Piscaglia","year":"2007","journal-title":"Gastroenterology"},{"issue":"03","key":"ref86","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1053\/j.gastro.2011.11.027","article-title":"Granulocyte colony-stimulating factor mobilizes CD34(+) cells and improves survival of patients with acute-on-chronic liver failure","volume":"142","author":"V Garg","year":"2012","journal-title":"Gastroenterology"},{"issue":"09","key":"ref87","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1038\/ajg.2014.154","article-title":"Granulocyte colony-stimulating factor in severe alcoholic hepatitis: a randomized pilot study","volume":"109","author":"V Singh","year":"2014","journal-title":"Am J Gastroenterol"},{"issue":"10","key":"ref88","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1016\/j.cgh.2018.01.040","article-title":"Efficacy of Granulocyte colony-stimulating factor and N-acetyl cysteine therapies in patients with severe alcoholic hepatitis","volume":"16","author":"V Singh","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"03","key":"ref89","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1002\/hep.30516","article-title":"Efficacy of Granulocyte colony-stimulating factor in the management of steroid \u2013 nonresponsive severe alcoholic hepatitis: a double blind randomized controlled trial","volume":"70","author":"S M Shasthry","year":"2019","journal-title":"Hepatology"},{"key":"ref90","doi-asserted-by":"publisher","DOI":"10.1016\/j.jceh.2016.06.052","article-title":"Effect of G-CSF on mortality and complications viz. sepsis, encephalopathy, HRS and GI bleed in severe alcoholic hepatitis \u2013 a randomized controlled study","author":"A Setia","year":"2016","journal-title":"J Clin Exp Hepatol"},{"issue":"07","key":"ref91","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1053\/j.gastro.2015.02.054","article-title":"Combination of granulocyte colony-stimulating factor and erythropoietin improves outcomes of patients with decompensated cirrhosis","volume":"148","author":"C K Kedarisetty","year":"2015","journal-title":"Gastroenterology"},{"issue":"04","key":"ref92","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1097\/MEG.0000000000000801","article-title":"Granulocyte colony-stimulating factor improves survival of patients with decompensated cirrhosis: a randomized-controlled trial","volume":"29","author":"R Prajapati","year":"2017","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"01","key":"ref93","doi-asserted-by":"crossref","first-page":"e53719","DOI":"10.1371\/journal.pone.0053719","article-title":"Autologous bone marrow mononuclear cell transplantation in patients with decompensated alcoholic liver disease: a randomized controlled trial","volume":"8","author":"L Spahr","year":"2013","journal-title":"PLoS One"},{"issue":"01","key":"ref94","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S2468-1253(17)30326-6","article-title":"Granulocyte colony-stimulating factor and autologous CD133-positive stem-cell therapy in liver cirrhosis (REALISTIC): an open-label, randomised, controlled phase 2 trial","volume":"3","author":"P N Newsome","year":"2018","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"03","key":"ref95","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.jhep.2017.09.013","article-title":"Controversies in clinical trials for alcoholic hepatitis","volume":"68","author":"S R Lieber","year":"2018","journal-title":"J Hepatol"},{"issue":"10","key":"ref96","doi-asserted-by":"crossref","first-page":"307","DOI":"10.3390\/jcm7100307","article-title":"Acute kidney injury definition and diagnosis: a narrative review","volume":"7","author":"J Gameiro","year":"2018","journal-title":"J Clin Med"},{"issue":"02","key":"ref97","first-page":"121","article-title":"Is macrophage activation syndrome a new entity?","volume":"20","author":"B H Athreya","year":"2002","journal-title":"Clin Exp Rheumatol"},{"issue":"02","key":"ref98","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1002\/pbc.21039","article-title":"HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis","volume":"48","author":"J I Henter","year":"2007","journal-title":"Pediatr Blood Cancer"},{"key":"ref99","doi-asserted-by":"publisher","first-page":"119","DOI":"10.3389\/fimmu.2019.00119","article-title":"The immunology of macrophage activation syndrome","volume":"10","author":"C B Crayne","year":"2019","journal-title":"Front Immunol"}],"container-title":["Seminars in Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/s-0040-1719177.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,20]],"date-time":"2023-10-20T21:52:49Z","timestamp":1697838769000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/s-0040-1719177"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":99,"journal-issue":{"issue":"01","published-online":{"date-parts":[[2021,3,10]]},"published-print":{"date-parts":[[2021,1]]}},"URL":"https:\/\/doi.org\/10.1055\/s-0040-1719177","relation":{},"ISSN":["0272-8087","1098-8971"],"issn-type":[{"value":"0272-8087","type":"print"},{"value":"1098-8971","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1]]}}}